Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6078993 | 0.89 | ALDH1A1 (0.55) | ALDH1A1LMNAGAA | |
| SCHEMBL6079328 | 0.86 | KMT2A (0.56) | KMT2AMEN1ALDH1A1TP53MIF | |
| SCHEMBL6079248 | 0.82 | MEN1 (0.58) | KMT2AMEN1ALDH1A1TP53 | |
| SCHEMBL6078214 | 0.82 | MEN1 (0.57) | KMT2AMEN1ALDH1A1HTTLMNA | |
| SCHEMBL6078636 | 0.81 | KMT2A (0.50) | KMT2AMEN1ALDH1A1TP53MIF | |
| SCHEMBL6079356 | 0.81 | MEN1 (0.56) | KMT2AMEN1ALDH1A1TP53MIF | |
| SCHEMBL6079195 | 0.78 | TP53 (0.60) | KMT2AMEN1ALDH1A1TP53 | |
| SCHEMBL6078640 | 0.77 | MEN1 (0.57) | KMT2AMEN1ALDH1A1TP53HTT | |
| SCHEMBL6078718 | 0.77 | MEN1 (0.49) | KMT2AMEN1ALDH1A1TP53MIF | |
| SCHEMBL6079241 | 0.77 | KMT2A (0.49) | KMT2AMEN1ALDH1A1TP53MIF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7071231-B2 | Naphthalene ureas as glucose uptake enhancers | TELIK, INC. (US) | 2006-07-04 | — | — | US | disclosed |
| US-6458998-B1 | NAPHTHALENEUREAS AS ANTIDIABETIC AGENTS | TELIK, INC. | 2002-10-01 | — | — | US | disclosed |